Share price: 112.80p

Director/PDMR Shareholding

21st September 2018

The Group provides the following notification in accordance with Article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alasdair Combe

2

Reason for the notification

a)

Position/status

Person closely associated with Jane Shirley, Joint CEO of Cello Health Insight and CEO of Cello Health Europe

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Purchase of ordinary shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£1.3487

10,000

d)

 

Aggregated information

– Aggregated volume

10,000

– Price

£13,487.00

e)

Date of the transaction

20 September 2018

f)

Place of the transaction

AIMX

 

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150